Xie, Xiaohong
Wu, Jianhui
Guo, Bingpeng
Wang, Liqiang
Deng, Haiyi
Lin, Xinqing
Liu, Ming
Qin, Yinyin
Luo, Wei
Yang, Yilin
Zou, Xiao
Hou, Ting
Xiang, Jianxing
Chen, Zhange
Zhou, Chengzhi
Funding for this research was provided by:
State Key Laboratory of Respiratory Disease - the Open Project (SKLRD-OP-202111)
Fundamental and Applied Fundamental Research Project of City-School (Institute) Joint Funding Project, Guangzhou Science and Technology Bureau (202102010345)
Beijing Xisike Clinical Oncology Research Foundation (Y-2019Genecast-076)
Beijing Bethune Charitable Foundation (BQE-TY-SSPC(5)-S-03)
Article History
Received: 1 March 2022
Accepted: 7 June 2022
First Online: 1 July 2022
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Review Committee of The First Affiliated Hospital of Guangzhou Medical University (No. 2020–26) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All patients had provided written informed consent for participating in the study.
: Not applicable.
: XZ, TH, JX, and ZC are employees of Burning Rock Biotech during the conduct of the study.